Ramsay Health Care (ASX:RHC): FY26 Hospital Earnings and the Proposed Santé Demerger

Aditi Sarkar

12 November 2026 04:39 PM AEDT

Ramsay Health Care (ASX:RHC): FY26 Hospital Earnings and the Proposed Santé Demerger

Image Source: Shutterstock

You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research. Learn more

Start Your Free Trial Now!

Highlights

Ramsay Health Care (ASX:RHC) reported FY26 underlying group EBIT of AUD 1,162.2 million.
Australian underlying EBIT rose 11.2% to AUD 639.8 million in FY26.
The proposed Ramsay Santé separation awaits November Shareholder meetings.
RHC shares were AUD 55.57 on 12 November 2026, down 0.89%.

Ramsay Health Care Limited (ASX:RHC) operates private hospitals, clinics and healthcare services across Australia, the United Kingdom and Europe. On 12 November 2026, Ramsay shares were quoted at AUD 55.57, down 0.89% during the session. Its latest 2026 developments centre on improved hospital earnings, Capital discipline and a proposed separation of Ramsay Santé. The separation remains subject to shareholder decisions and should not be treated as completed.

Hospital Operations Across Three Regions

Ramsay Health Care (ASX:RHC) reports activities spanning Australian hospitals, the Ramsay UK acute hospital business, Elysium mental healthcare in the UK and Ramsay Santé in continental Europe. Performance varies between these operations because patient volumes, reimbursement arrangements, staffing requirements and hospital capacity differ by market. The company’s Australian network serves patients undergoing inpatient and day procedures, while its European activities operate through separate healthcare systems. These distinctions matter when comparing segment operating results.

FY26 Results and Operating Drivers

For the year ended 30 June 2026, Ramsay Health Care (ASX:RHC) reported underlying group Earnings before interest and tax (EBIT) of AUD 1,162.2 million, up 11.5%. Underlying group earnings before interest, tax, Depreciation and Amortisation (EBITDA) reached AUD 2,343.4 million, an 8.0% increase. Underlying segment Revenue and other income, excluding interest income, was AUD 18,659.6 million, an increase of 4.9%. These are underlying measures and should be distinguished from statutory results.

Australian underlying EBIT increased 11.2% to AUD 639.8 million. The company attributed the improvement to activity growth, a higher-acuity mix, better theatre utilisation, private Health Insurance indexation and cost management. Ramsay UK acute hospital EBIT rose 9.0% to AUD 160.5 million, while Elysium EBIT increased to AUD 31.1 million from AUD 22.0 million. Ramsay Santé underlying EBIT reached AUD 330.8 million, up 11.1%. The divergent operating environments mean these segment figures should not be interpreted as uniform Demand trends.

Proposed Ramsay Santé Separation

The proposed demerger of Ramsay Santé is a central corporate development for Ramsay Health Care (ASX:RHC). The company published a demerger booklet in October 2026 and scheduled shareholder meetings for 24 November 2026. The planned structure is intended to separate European operations from the remaining Ramsay businesses, but voting and other applicable conditions still matter. A potential change in group composition would also affect how future reported earnings and financial measures are compared. Any discussion of the post-separation group therefore depends on formal completion and subsequent disclosures.

Risks and Operational Milestones

Hospital operators face staffing availability, wage inflation, clinical quality requirements, reimbursement changes and the cost of maintaining medical facilities. For Ramsay Health Care (ASX:RHC), differences between Australian private patient activity and UK public healthcare demand can affect profitability. Financing costs and Capital Expenditure are additional considerations, particularly for a Business operating substantial property and clinical infrastructure. Proposed corporate reorganisations carry timing, voting and execution risks, and announced plans do not establish a completed outcome.

What to Watch Next

The immediate dated milestone is the 24 November 2026 meeting process regarding Ramsay Santé, alongside Ramsay’s annual general meeting. Investors may monitor the published voting results, any implementation timetable and how the company presents its continuing operations. Subsequent trading updates can clarify theatre utilisation, Australian hospital case mix, UK activity, cash generation and financing costs. Ramsay Health Care (ASX:RHC) will also have to distinguish operational improvements from changes caused by a possible group restructuring.

Key Insights

Ramsay’s FY26 accounts recorded increased underlying EBIT across its major disclosed operating segments, while the proposed Santé transaction remained conditional. The combination of hospital activity, cost management and the outcome of the November meetings will inform later disclosures. Underlying measures provide operating context but are not substitutes for the company’s full statutory accounts.

Download Free Report – Explore 3 Stock Ideas & Industry Insights

Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.

All investments involve risk—consider independent advice before making any investment decisions.

View 3 Research Reports

Disclaimer:

This article (“Article”) has been prepared by Kalkine Pty Limited (ABN 34 154 808 312) (Australian financial services licence number 425376) (“Kalkine”) and its related bodies corporate who are authorised to provide general financial product advice. Kalkine.com.au and its associated pages are published by Kalkine.

Any information/advice provided in this article is general in nature and does not take into account your objectives, financial situation or needs. You should therefore consider whether the information is appropriate for your objectives, financial situation and needs before acting upon it.

There may be a Product Disclosure Statement, Information Memorandum or other offer document (“Offer Document”) for the securities or other financial products referred to in Kalkine articles. You should obtain a copy of the Offer Document and consider it before making any decision about whether to acquire the security or financial product.

Kalkine strongly recommends that you seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) before acting on any advice/information in this Article or on the Kalkine website. Not all investments are appropriate for all people.

The information in this Article and on Kalkine website has been prepared from a wide variety of sources, which Kalkine, to the best of its knowledge and belief, considers accurate. Kalkine has made every effort to ensure the reliability of the information contained in its articles (including this Article), newsletters and websites. All information represents our views at the date of publication and may change without notice.

The information in this Article does not constitute an offer to sell securities or other financial products or a solicitation of an offer to buy securities or other financial products.

Kalkine does not issue, sell or deal in any financial products.

This Article may contain information on past performance of particular investments. Please note past performance is neither an indicator nor a guarantee of future performance.

To the extent permitted by law, and excluding any dishonesty or gross negligence by Kalkine, Kalkine disclaims and excludes all liability for any direct, indirect, implied, punitive, special, incidental or other consequential loss or damage arising from the use of or reliance on this Article, the Kalkine website and any information published on the Kalkine website without any warranties or representations by Kalkine to you. To the extent the law prohibits or limits this exclusion, Kalkine limits its liability to the resupply of services.

Please also read our Terms & Conditions and Financial Services Guide for further information.

Employees and/or associates of Kalkine and its related entities may hold interests in the securities or other financial products covered in this Article or on the Kalkine website. Any such employees and associates are required to comply with certain safeguards, procedures and disclosures as required by law.

Some of the images/music that may be used in the Article are copyright to their respective owner(s). Kalkine does not claim ownership of any of the pictures displayed/music used in the Article unless stated otherwise. The images/music that may be used in the Article are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated or was found to be necessary.

Kalkine Media Pty Ltd, an affiliate of Kalkine Pty Ltd, may have received, or be entitled to receive, financial consideration in connection with providing information about certain entity(s) covered on its website.